Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration

Nature Medicine

Volumn 9, Issue 6, 2003, Pages 702-712

  Rafii, Shahin ^a   Lyden, David ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CHEMOKINE;

BONE MARROW; CELL DIFFERENTIATION; CELL MIGRATION; CLINICAL TRIAL; ENDOTHELIUM CELL; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC CELL; HUMAN; LIMB ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RETINA ISCHEMIA; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; VASCULARIZATION;

ANIMALS; CELL DIFFERENTIATION; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 0038376000     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0603-702     Document Type: Review

References (143)

1. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31 (1995).
2. Folkman, J. Therapeutic angiogenesis in ischemic limbs. Circulation 97, 1108-1110 (1998).
3. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996).
4. Risau, W. Mechanisms of angiogenesis. Nature 386, 671-674 (1997).
5. Yancopoulos, G.D. et al. Vascular-specific growth factors and blood vessel formation. Nature 407, 242-248 (2000).
6. Carmeliet, P. & Jain, R.K. Angiogenesis in cancer and other diseases. Nature 407, 249-257 (2000).
7. Pepper, M.S. Manipulating angiogenesis. From basic science to the bedside. Arterioscler. Thromb. Vasc. Biol. 17, 605-619 (1997).
8. Isner, J.M. Myocardial gene therapy. Nature 415, 234-239 (2002).
9. Khurana, R. & Simons, M. Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease. Trends Cardiovasc. Med. 13, 116-122 (2003).
10. Cao, R. et al. Angiogenic synergism, vascular stability and improvement of hindlimb ischemia by a combination of PDGF-BB and FGF-2. Nat. Med. 9, 604-613 (2003).
11. Carmeliet, P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat. Med. 6, 1102-1103 (2000).
12. Majka, S.M. et al. Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J. Clin. Invest. 111, 71-79 (2003).
13. Asahara, T. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967 (1997).
14. Asahara, T. et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85, 221-228 (1999).
15. Asahara, T. et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J. 18, 3964-3972 (1999).
16. Iwaguro H. et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105, 732-738 (2002).
17. Kalka, C. et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97, 3422-3427 (2000).
18. Schatteman, G.C., Hanlon, H.D., Jiao, C., Dodds, S.G. & Christy, B.A. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J. Clin. Invest. 106, 571-578 (2000).
19. Crosby, J.R. et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ. Res. 87, 728-730 (2000).
20. Takahashi, T. et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434-438 (1999).
21. Luttun, A., Carmeliet, G. & Carmeliet, P. Vascular progenitors: from biology to treatment. Trends Cardiovasc. Med. 12, 88-96 (2002).
22. Rafii, S. Circulating endothelial precursors: mystery, reality, and promise. J. Clin. Invest. 105, 17-19 (2000).
23. Orlic, D. et al. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001).
24. Orlic, D. et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98, 10344-10349 (2001).
25. Kocher, A.A. et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436 (2001).
26. Jackson, K.A. et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107, 1395-1402 (2001).
27. Edelberg, J.M., Tang, L., Hattori, K., Lyden, D. & Rafii, S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ. Res. 90, E89-E93 (2002).
28. Shi, Q. et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92, 362-367 (1998).
29. + bone marrow cells. Blood 95, 581-585 (2000).
30. Kaushal, S. et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med. 7, 1035-1040 (2001).
31. Noishiki, Y., Tomizawa, Y., Yamane, Y. & Matsumoto, A. Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat. Med. 2, 90-93 (1996).
32. Sata, M. et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8, 403-409 (2002).
33. Otani, A. et al. Bone marrow derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 8, 1004-1010 (2002).
34. Grant, M.B. et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 8, 607-612 (2002).
35. Crisa, L. et al. Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood 94, 3928-3940 (1999).
36. Young, P.P., Hofling, A.A. & Sands, M.S. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc. Natl. Acad. Sci. USA 99, 11951-11956 (2002).
37. Lyden, D. et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194-1201 (2001).
38. Reyes, M. et al. Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109, 337-346 (2002).
39. Moore, M.A. Putting the neo into neoangiogenesis. J. Clin. Invest. 109, 313-315 (2002).
40. Gehling, U.M. et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95, 3106-3112 (2000).
41. Marchetti, S. et al. Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo. J. Cell. Sci. 115, 2075-2085 (2002).
42. Davidoff, A.M. et al. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin. Cancer Res. 7, 2870-2879 (2001).
43. Segal, M.S., Bihorac, A. & Koc, M. Circulating endothelial cells: tea leaves for renal disease. Am. J. Physiol. Renal Physiol. 283, F11-F19 (2002).
44. Mutunga, M. et al. Circulating endothelial cells in patients with septic shock. Am. J. Respir. Crit. Care Med. 163, 195-200 (2001).
45. George, F. et al. Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb. Haemost. 67, 147-153 (1992).
46. George, F. et al. Cytofluorometric detection of human endothelial cells in whole blood using S-Endo 1 monoclonal antibody. J. Immunol. Meth. 139, 65-75 (1991).
47. Drancourt, M., George, F., Brouqui, P., Sampol, J. & Raoult, D. Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads. J. Infect. Dis. 166, 660-663 (1992).
48. Shi, Q. et al. Proof of fallout endothelialization of impervious Dacron grafts in the aorta and inferior vena cava of the dog. J. Vasc. Surg. 20, 546-557 (1994).
49. Bergers, G., Javaherian, K., Lo, K.M., Folkman, J. & Hanahan, D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284, 808-812 (1999).
50. Solovey, A. et al. Circulating activated endothelial cells in sickle cell anemia. N. Engl. J. Med. 337, 1584-1590 (1997).
51. Lin, Y., Weisdorf, D.J., Solovey, A. & Hebbel, R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J. Clin. Invest. 105, 71-77 (2000).
52. Peichev, M. et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95, 952-958 (2000).
53. Coffin, J.D., Harrison, J., Schwartz, S. & Heimark, R. Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Dev. Biol. 148, 51-62 (1991).
54. Caprioli, A., Jaffredo, T., Gautier, R., Dubourg, C. & Dieterlen-Lievre, F. Blood-borne seeding by hematopoietic and endothelial precursors from the allantois. Proc. Natl. Acad. Sci. USA 95, 1641-1646 (1998).
55. Schmeisser, A. et al. Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc. Res. 49, 671-680 (2001).
56. Rehman, J., Li, J., Orschell, C.M. & March, K.L. Peripheral blood endothelial progenitor cells are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107, 1164-1169 (2003).
57. Solovey, A.N. et al. Identification and functional assessment of endothelial P1H12. J. Lab. Clin. Med. 138, 322-331 (2001).
58. Rafii, S., Lyden, D., Benezra, R., Hattori, K. & Heissig, B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat. Rev. Cancer 2, 826-835 (2002).
59. Shi, Q., Bhattacharya, V., Hong-De Wu, M. & Sauvage, L.R. Utilizing granulocyte colony-stimulating factor to enhance vascular graft endothelialization from circulating blood cells. Ann. Vasc. Surg. 16, 314-320 (2002).
60. Yin, A.H. et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90, 5002-5012 (1997).
61. Miraglia, S. et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90, 5013-5021 (1997).
62. Quirici, N. et al. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br. J. Haematol. 115, 186-194 (2001).
63. + lymphatic/vascular endothelial precursor cells. Blood 101, 168-172 (2003).
64. Yamashita, J. et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408, 92-96 (2000).
65. Schuh, A.C., Faloon, P., Hu, Q.L., Bhimani, M. & Choi, K. In vitro hematopoietic and endothelial potential of flk-1(-/-) embryonic stem cells and embryos. Proc. Natl. Acad. Sci. USA 96, 2159-2164 (1999).
66. Hatzopoulos, A.K., Folkman, J., Vasile, E., Eiselen, G.K. & Rosenberg, R.D. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125, 1457-1468 (1998).
67. Levenberg, S., Golub, J.S., Amit, M., Itskovitz-Eldor, J. & Langer, R. Endothelial cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 99, 4391-4396 (2002).
68. Jiang, Y. et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 (2002).
69. Rafii, S. et al. Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann. Thorac. Surg. 60, 1627-1632 (1995).
70. Hattori, K. et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193, 1005-1014 (2001).
71. Hattori, K. et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med. 8, 841-849 (2002).
72. Rabbany, S.Y., Heissig, B., Hattori, K. & Rafii, S. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol. Med. 9, 109-117 (2003).
73. Gill, M. et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ. Res. 88, 167-174 (2001).
74. Vasa, M. et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103, 2885-2890 (2001).
75. Shintani, S. et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103, 2776-2779 (2001).
76. Rafii, S., Heissig, B. & Hattori, K. Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther. 9, 631-641 (2002).
77. Heissig, B. et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637 (2002).
78. Eriksson, U. & Alitalo, K. VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies. Nat. Med. 8, 775-777 (2002).
79. Dahlqvist, K., Umemoto, E.Y., Brokaw, J.J., Dupuis, M. & McDonald, D.M. Tissue macrophages associated with angiogenesis in chronic airway inflammation in rats. Am. J. Respir. Cell. Mol. Biol. 20, 237-247 (1999).
80. Ezaki, T. et al. Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am. J. Pathol. 158, 2043-2055 (2001).
81. McDonald, D.M. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am. J. Respir. Crit. Care Med. 164, S39-S45 (2001).
82. DiPietro, L.A. & Polverini, P.J. Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1. Am. J. Pathol. 143, 678-684 (1993).
83. Polverini, P.J. & Leibovich, S.J. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab. Invest. 51, 635-642 (1984).
84. Polverini, P.J., Cotran, P.S., Gimbrone, M.A., Jr. & Unanue, E.R. Activated macrophages induce vascular proliferation. Nature 269, 804-806 (1977).
85. Leibovich, S.J. et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α. Nature 329, 630-632 (1987).
86. Mohle, R., Green, D., Moore, M.A., Nachman, R.L. & Rafii, S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. USA 94, 663-668 (1997).
87. Salven, P., Hattori, K., Heissig, B. & Rafii, S. Interleukin-1α promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J. 16, 1471-1473 (2002).
88. Pintucci, G. et al. Trophic effects of platelets on cultured endothelial cells are mediated by platelet-associated fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF). Thromb. Haemost. 88, 834-842 (2002).
89. Ribatti, D., Vacca, A., Roncati, L. & Dammacco, F. Hematopoiesis and angiogenesis: a link between two apparently independent processes. J. Hematother. Stem Cell Res. 9, 13-19 (2000).
90. Tordjman, R. et al. Erythroblasts are a source of angiogenic factors. Blood 97, 1968-1974 (2001).
91. Wartiovaara, U. et al. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb. Haemost. 80, 171-175 (1998).
92. Huang, Y.Q., Li, J.J. & Karpatkin, S. Identification of a family of alternatively spliced mRNA species of angiopoietin-1. Blood 95, 1993-1999 (2000).
93. Coussens, L.M., Tinkle, C.L., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490 (2000).
94. Takakura, N. et al. A role for hematopoietic stem cells in promoting angiogenesis. Cell 102, 199-209 (2000).
95. Abtahian, F. et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299, 247-251 (2003).
96. Rafii, S. & Skobe, M. Splitting vessels: keeping lymph apart from blood. Nat. Med. 9, 166-168 (2003).
97. Hess, D.C. et al. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 33, 1362-1368 (2002).
98. Zhang, Z.G., Zhang, L., Jiang, Q. & Chopp, M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ. Res. 90, 284-288 (2002).
99. Luttun, A. et al. Revascularization of ischemic tissues by PIGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8, 831-840 (2002).
100. Caplice, N.M. et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc. Natl. Acad. Sci. USA 100, 4754-4759 (2003).
101. Hill, J.M. et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600 (2003).
102. Hillebrands, J.L., Klatter, F.A., van den Hurk Popa, E.R., Nieuwenhuis, P. & Rozing, J. Origin of neointimal endothelium and α-actin-positive smooth muscle cells in transplant arteriosclerosis. J. Clin. Invest. 107, 1411-1422 (2001).
103. Hillebrands, J.L., Klatter, F.A., van Dijk W.D. & Rozing, J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat. Med. 8, 194-195 (2002).
104. Shimizu, K. et al. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat. Med. 7, 738-741 (2001).
105. Hu, Y. et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 106, 1834-1839 (2002).
106. Hillebrands, J.L., Klatter, F.A. & Rozing, J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler. Thromb. Vasc. Biol. 23, 380-387 (2003).
107. Wagers, A.J., Sherwood, R.I., Christensen, J.L. & Weissman, I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297, 2256-2259 (2002).
108. Krause, D.S. et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105, 369-377 (2001).
109. Walter, D.H. et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105, 3017-3024 (2002)
110. Isner, J.M., Kalka, C., Kawamoto, A. & Asahara, T. Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair. Ann. NY Acad. Sci. 953, 75-84 (2001).
111. Iba, O. et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation 106, 2019-2025 (2002).
112. Tateishi-Yuyama, E. et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360, 427-435 (2002).
113. Yoon, Y.S. et al. VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. J. Clin. Invest. 111, 717-725 (2003).
114. Saaristo, A., Karkkainen, M.J. & Alitalo, K. Insights into the molecular pathogenesis and targeted treatment of lymphedema. Ann. NY Acad. Sci. 979, 94-110 (2002).
115. Szuba, A. et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J. 16, 1985-1987 (2002).
116. Orlic, D. et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. NY Acad. Sci. 938, 221-230 (2001).
117. Kawamoto, A. et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107, 461-468 (2003).
118. Kawamoto, A. et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103, 634-637 (2001).
119. Kamihata, H. et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104, 1046-1052 (2001).
120. Tomita, S. et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100, 11247-11256 (1999).
121. Fuchs, S. et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J. Am. Coll. Cardiol. 37, 1726-1732 (2001).
122. Kobayashi, T. et al. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J. Surg. Res. 89, 189-195 (2000).
123. Kamihata, H. et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler. Thromb. Vasc. Biol. 22, 1804-1810 (2002).
124. Strauer, B.E. et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913-1918 (2002).
125. Perin, E.C. et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation, published online 21 April 2003 (doi: 10.1161/01.ClR.0000070596.30552.8B).
126. Tse, H.F. et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361, 47-49 (2003).
127. Assmus, B. et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106, 3009-3017 (2002).
128. Lee, R.J. et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102, 898-901 (2000).
129. Epstein, S.E., Kornowski, R., Fuchs, S. & Dvorak, H.F. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 104, 115-119 (2001).
130. Stamm, C. et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361, 45-46 (2003).
131. Celletti, F.L. et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med. 7, 425-429 (2001).
132. Moulton, K.S. et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal. Circulation 99, 1726-1732 (1999).
133. van Royen, N. et al. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression. Circ. Res. 92, 218-225 (2003).
134. Terada, N. et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542-545 (2002).
135. V, integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest. 103, 1227-1230 (1999).
136. Hynes, R.O. A reevaluation of integrins as regulators of angiogenesis. Nat. Med. 8, 918-921 (2002).
137. Wijelath, E.S. et al. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ. Res. 91, 25-31 (2002).
138. Donovan, M.J. et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 127, 4531-4540 (2000).
139. LeCouter, J. et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412, 877-884 (2001).
140. Tepper, O.M. et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781-2786 (2002).
141. Dimmeler, S. et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108, 391-397 (2001).
142. Waltenberger, J., Lange, J. & Kranz, A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation 102, 185-190 (2000).
143. Murasawa, S. et al. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106, 1133-1139 (2002).